Compensatory RBP Expression Therapy
🧪 Overview
Gene therapy approaches to upregulate functional RBPs that can compensate for lost function in disease-affected proteins. This would restore RNA processing networks through redundant pathways.
Debate provenance: derived from debate `sess_sda-2026-04-01-gap-v2-68d9c9c1` on question: RNA binding protein dysregulation across ALS FTD and AD. Consensus signal: skeptic, synthesizer, theorist discussed the mechanism terms Compensatory, ELAVL1, Expression, RBP, RNA. Novelty signal: skeptic-discussed-with-qualified-concession.
🧬 Mechanism
Auto-built from this analysis's top knowledge-graph edges.
graph TD
TDP_43["TDP-43"] -->|associated with| AD["AD"]
TARDBP["TARDBP"] -->|risk factor for| ALS_FTD["ALS-FTD"]
FUS["FUS"] -->|risk factor for| ALS_FTD_1["ALS-FTD"]
RNA_Splicing["RNA Splicing"] -->|associated with| als["als"]
RNA_Splicing_2["RNA Splicing"] -->|associated with| ftd["ftd"]
Rbp_Dysfunction["Rbp Dysfunction"] -->|associated with| als_3["als"]
Rbp_Dysfunction_4["Rbp Dysfunction"] -->|associated with| ftd_5["ftd"]
G3BP1["G3BP1"] -->|regulates| Stress_Granules["Stress Granules"]
TDP_43_6["TDP-43"] -->|associated with| als_7["als"]
TDP_43_8["TDP-43"] -->|associated with| ftd_9["ftd"]
SETX["SETX"] -->|associated with| neurodegeneration["neurodegeneration"]
h_97aa8486["h-97aa8486"] -->|implicated in| neurodegeneration_10["neurodegeneration"]
style TDP_43 fill:#4fc3f7,stroke:#333,color:#000
style AD fill:#ef5350,stroke:#333,color:#000
style TARDBP fill:#ce93d8,stroke:#333,color:#000
style ALS_FTD fill:#ef5350,stroke:#333,color:#000
style FUS fill:#ce93d8,stroke:#333,color:#000
style ALS_FTD_1 fill:#ef5350,stroke:#333,color:#000
style RNA_Splicing fill:#4fc3f7,stroke:#333,color:#000
style als fill:#ef5350,stroke:#333,color:#000
style RNA_Splicing_2 fill:#4fc3f7,stroke:#333,color:#000
style ftd fill:#ef5350,stroke:#333,color:#000
style Rbp_Dysfunction fill:#4fc3f7,stroke:#333,color:#000
style als_3 fill:#ef5350,stroke:#333,color:#000
style Rbp_Dysfunction_4 fill:#4fc3f7,stroke:#333,color:#000
style ftd_5 fill:#ef5350,stroke:#333,color:#000
style G3BP1 fill:#ce93d8,stroke:#333,color:#000
style Stress_Granules fill:#4fc3f7,stroke:#333,color:#000
style TDP_43_6 fill:#4fc3f7,stroke:#333,color:#000
style als_7 fill:#ef5350,stroke:#333,color:#000
style TDP_43_8 fill:#4fc3f7,stroke:#333,color:#000
style ftd_9 fill:#ef5350,stroke:#333,color:#000
style SETX fill:#ce93d8,stroke:#333,color:#000
style neurodegeneration fill:#ef5350,stroke:#333,color:#000
style h_97aa8486 fill:#4fc3f7,stroke:#333,color:#000
style neurodegeneration_10 fill:#ef5350,stroke:#333,color:#000⚖️ Evidence
No linked papers recorded for this hypothesis yet.
🏥 Translation
🧬 3D Protein Structure — ELAVL1
No curated PDB or AlphaFold mapping for ELAVL1 yet. Search RCSB →
💉 Clinical Trials
No clinical trials data linked to this hypothesis yet.
No curated ClinVar variants loaded for this hypothesis.
Run scripts/backfill_clinvar_variants.py to fetch P/LP/VUS variants.
No DepMap CRISPR Chronos data found for ELAVL1.
Run python3 scripts/backfill_hypothesis_depmap.py to populate.
🏆 Tournament
🏆 Arenas / Elo
📊 Market Indicators
💾 Resource Usage
▸Metadatasource: v1_phase_c_backfill · origin_type: debate_round_mining
| source | v1_phase_c_backfill |
| origin_type | debate_round_mining |
| _schema_version | 1 |